3,4-MDEA (hydrochloride)

• CAT Number: R064631
• CAS Number: 74341-78-9
• Molecular Formula: C12H18ClNO2
• Molecular Weight: 243.731
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: 1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine;hydrochloride
• InChI: InChI=1S/C12H17NO2.ClH/c1-3-13-9(2)6-10-4-5-11-12(7-10)15-8-14-11;/h4-5,7,9,13H,3,6,8H2,1-2H3;1H
• InChIKey: IBDIPBWIXJRJQM-UHFFFAOYSA-N
• SMILES: CCNC(C)CC1=CC2=C(C=C1)OCO2.Cl

3,4-MDEA (hydrochloride) (Item No. 14085) is an analytical reference standard that is structurally categorized as an amphetamine. It has similar psychotropic action to methylenedioxyamphetamine (MDMA) and shares the common name of /ecstasy/. Both methylenedioxyamphetamines are regulated as Schedule I drugs in the United States. In rats, 3,4-MDEA produces significant retention deficits in learning tasks and is similar to 3,4-MDMA (Item No. 13971) in inducing serotonin release from frontal cortex/hippocampal synaptosomes. Postmortem findings in human deaths associated with 3,4-MDEA as well as 3,4-MDMA indicate striking brain and myocardial damage as well as liver necrosis. This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO/IEC 17025 and ISO Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.

Reference

1.Freudenmann, R.W., and Spitzer, M. The neuropsychopharmacology and toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). CNS Drug Rev. 10, 89-116 (2004).